GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 204 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2022. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $3,295,259,000 | -0.2% | 103,138 | +8.2% | 0.03% | +11.1% |
Q1 2022 | $3,301,434,000 | +815.5% | 95,307 | +673.5% | 0.03% | +800.0% |
Q4 2021 | $360,635,000 | -5.3% | 12,321 | -17.6% | 0.00% | 0.0% |
Q3 2021 | $380,798,000 | +165464.3% | 14,945 | +232.1% | 0.00% | -25.0% |
Q1 2020 | $230,000 | -58.3% | 4,500 | -35.2% | 0.00% | 0.0% |
Q4 2019 | $552,000 | +146.4% | 6,941 | +50.5% | 0.00% | +100.0% |
Q3 2019 | $224,000 | -86.7% | 4,612 | -89.6% | 0.00% | -77.8% |
Q3 2018 | $1,688,000 | – | 44,413 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |